{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:38:25Z","timestamp":1761561505066},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1673,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1530-0277.2010.01402.x","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T21:38:17Z","timestamp":1296596297000},"page":"804-805","source":"Crossref","is-referenced-by-count":5,"title":["Management of Alcoholic Liver Disease: An Update"],"prefix":"10.1111","volume":"35","author":[{"given":"David","family":"Kershenobich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana Lau","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Kershenovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Gutierrez-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,1]]},"reference":[{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of Baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis; randomized, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.3194","article-title":"Pentoxifylline: a first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome?","volume":"15","author":"Assimakopoulos","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00204-009-0432-0","article-title":"Role of oxidative stress in alcohol-induced liver injury","volume":"83","author":"Cederbaum","year":"2009","journal-title":"Arch Toxicol"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-\u03bab and the hepatic inflammation-fibrosis-cancer axis","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2004-832941","article-title":"Nutrition and alcoholic liver disease","volume":"24","author":"Halsted","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.brainres.2009.09.093","article-title":"The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin","volume":"1305","author":"Hammarberg","year":"2009","journal-title":"Brain Res"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","article-title":"Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study","volume":"42","author":"Kirpich","year":"2008","journal-title":"Alcohol"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double-blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cld.2004.11.004","article-title":"Treatment of alcoholic hepatitis","volume":"9","author":"O\u2019Shea","year":"2005","journal-title":"Clin Liv Dis"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB11|cit11","volume-title":"Cochrane Database Syst Rev [database online]","author":"Rambaldi","year":"2005"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","article-title":"Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial","volume":"50","author":"Sharma","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-2952(00)00435-4","article-title":"Role of disulfiram in the in vitro inhibition of rat liver mitochondrial aldehyde dehydrogenase","volume":"60","author":"Shen","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/msj.20135","article-title":"Controversies in the management of alcoholic liver disease","volume":"76","author":"Tan","year":"2009","journal-title":"Mt Sinai J Med"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease","volume":"42","author":"Tian","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.1530-0277.2010.01402.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","article-title":"Alcohol-related cirrhosis-early abstinence is a key factor in prognosis, even in the most severe cases","volume":"5","author":"Verrill","year":"2009","journal-title":"Addiction"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2010.01402.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1530-0277.2010.01402.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T09:00:00Z","timestamp":1612688400000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1111\/j.1530-0277.2010.01402.x"}},"subtitle":["MANAGEMENT OF ALCOHOLIC LIVER DISEASE"],"short-title":[],"issued":{"date-parts":[[2011,2,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2010.01402.x","relation":{},"ISSN":["0145-6008"],"issn-type":[{"value":"0145-6008","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,1]]}}}